Global Hepatocyte Growth Factor Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

45871

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

121

Market Scenario

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing. Scope of the Report: The application of hepatocyte growth factor includes oncology, cardiovascular, central nervous system, hematological disorders and others, and the proportion of R&D Investment for oncology in 2017 is about 36%, and the proportion is in decreasing trend from 2012 to 2016. Asia Pacific will be the largest market, which will occupy nearly 62% market share in 2030. Following Asia Pacific, North America will be the second largest market with the consumption market share of 25% in 2030. The worldwide market for Hepatocyte Growth Factor is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Hepatocyte Growth Factor in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers ViroMed AnGes MG M3 Biotechnology AVEO Pharmaceuticals Molecular Partners Yooyoung Pharm F-star Galaxy Biotech Kringle Pharma Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Type I Type II Market Segment by Applications, can be divided into Oncology Cardiovascular Central Nervous System Hematological Disorders Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Hepatocyte Growth Factor product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Hepatocyte Growth Factor, with price, sales, revenue and global market share of Hepatocyte Growth Factor in 2017 and 2018. Chapter 3, the Hepatocyte Growth Factor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Hepatocyte Growth Factor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Hepatocyte Growth Factor market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Hepatocyte Growth Factor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Hepatocyte Growth Factor Introduction 1.2 Market Analysis by Type 1.2.1 Type I 1.2.2 Type II 1.3 Market Analysis by Applications 1.3.1 Oncology 1.3.2 Cardiovascular 1.3.3 Central Nervous System 1.3.4 Hematological Disorders 1.3.5 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 ViroMed 2.1.1 Business Overview 2.1.2 Hepatocyte Growth Factor Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 ViroMed Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 AnGes MG 2.2.1 Business Overview 2.2.2 Hepatocyte Growth Factor Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 AnGes MG Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 M3 Biotechnology 2.3.1 Business Overview 2.3.2 Hepatocyte Growth Factor Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 AVEO Pharmaceuticals 2.4.1 Business Overview 2.4.2 Hepatocyte Growth Factor Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Molecular Partners 2.5.1 Business Overview 2.5.2 Hepatocyte Growth Factor Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Yooyoung Pharm 2.6.1 Business Overview 2.6.2 Hepatocyte Growth Factor Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 F-star 2.7.1 Business Overview 2.7.2 Hepatocyte Growth Factor Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 F-star Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Galaxy Biotech 2.8.1 Business Overview 2.8.2 Hepatocyte Growth Factor Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Kringle Pharma 2.9.1 Business Overview 2.9.2 Hepatocyte Growth Factor Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Hepatocyte Growth Factor Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Hepatocyte Growth Factor Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Hepatocyte Growth Factor Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Hepatocyte Growth Factor Manufacturer Market Share in 2018 3.3.2 Top 6 Hepatocyte Growth Factor Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Hepatocyte Growth Factor Market Analysis by Regions 4.1 Global Hepatocyte Growth Factor Sales, Revenue and Market Share by Regions 4.1.1 Global Hepatocyte Growth Factor Sales and Market Share by Regions (2014-2019) 4.1.2 Global Hepatocyte Growth Factor Revenue and Market Share by Regions (2014-2019) 4.2 North America Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 4.3 Europe Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 4.5 South America Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 5 North America Hepatocyte Growth Factor by Country 5.1 North America Hepatocyte Growth Factor Sales, Revenue and Market Share by Country 5.1.1 North America Hepatocyte Growth Factor Sales and Market Share by Country (2014-2019) 5.1.2 North America Hepatocyte Growth Factor Revenue and Market Share by Country (2014-2019) 5.2 United States Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 5.3 Canada Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 5.4 Mexico Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 6 Europe Hepatocyte Growth Factor by Country 6.1 Europe Hepatocyte Growth Factor Sales, Revenue and Market Share by Country 6.1.1 Europe Hepatocyte Growth Factor Sales and Market Share by Country (2014-2019) 6.1.2 Europe Hepatocyte Growth Factor Revenue and Market Share by Country (2014-2019) 6.2 Germany Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 6.3 UK Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 6.4 France Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 6.5 Russia Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 6.6 Italy Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 7 Asia-Pacific Hepatocyte Growth Factor by Country 7.1 Asia-Pacific Hepatocyte Growth Factor Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Hepatocyte Growth Factor Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Hepatocyte Growth Factor Revenue and Market Share by Country (2014-2019) 7.2 China Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 7.3 Japan Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 7.4 Korea Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 7.5 India Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 8 South America Hepatocyte Growth Factor by Country 8.1 South America Hepatocyte Growth Factor Sales, Revenue and Market Share by Country 8.1.1 South America Hepatocyte Growth Factor Sales and Market Share by Country (2014-2019) 8.1.2 South America Hepatocyte Growth Factor Revenue and Market Share by Country (2014-2019) 8.2 Brazil Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 8.3 Argentina Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 8.4 Colombia Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 9 Middle East and Africa Hepatocyte Growth Factor by Countries 9.1 Middle East and Africa Hepatocyte Growth Factor Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Hepatocyte Growth Factor Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Hepatocyte Growth Factor Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 9.3 Turkey Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 9.4 Egypt Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 9.5 Nigeria Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 9.6 South Africa Hepatocyte Growth Factor Sales and Growth Rate (2014-2019) 10 Global Hepatocyte Growth Factor Market Segment by Type 10.1 Global Hepatocyte Growth Factor Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Hepatocyte Growth Factor Sales and Market Share by Type (2014-2019) 10.1.2 Global Hepatocyte Growth Factor Revenue and Market Share by Type (2014-2019) 10.2 Type I Sales Growth and Price 10.2.1 Global Type I Sales Growth (2014-2019) 10.2.2 Global Type I Price (2014-2019) 10.3 Type II Sales Growth and Price 10.3.1 Global Type II Sales Growth (2014-2019) 10.3.2 Global Type II Price (2014-2019) 11 Global Hepatocyte Growth Factor Market Segment by Application 11.1 Global Hepatocyte Growth Factor Sales Market Share by Application (2014-2019) 11.2 Oncology Sales Growth (2014-2019) 11.3 Cardiovascular Sales Growth (2014-2019) 11.4 Central Nervous System Sales Growth (2014-2019) 11.5 Hematological Disorders Sales Growth (2014-2019) 11.6 Others Sales Growth (2014-2019) 12 Hepatocyte Growth Factor Market Forecast (2019-2024) 12.1 Global Hepatocyte Growth Factor Sales, Revenue and Growth Rate (2019-2024) 12.2 Hepatocyte Growth Factor Market Forecast by Regions (2019-2024) 12.2.1 North America Hepatocyte Growth Factor Market Forecast (2019-2024) 12.2.2 Europe Hepatocyte Growth Factor Market Forecast (2019-2024) 12.2.3 Asia-Pacific Hepatocyte Growth Factor Market Forecast (2019-2024) 12.2.4 South America Hepatocyte Growth Factor Market Forecast (2019-2024) 12.2.5 Middle East and Africa Hepatocyte Growth Factor Market Forecast (2019-2024) 12.3 Hepatocyte Growth Factor Market Forecast by Type (2019-2024) 12.3.1 Global Hepatocyte Growth Factor Sales Forecast by Type (2019-2024) 12.3.2 Global Hepatocyte Growth Factor Market Share Forecast by Type (2019-2024) 12.4 Hepatocyte Growth Factor Market Forecast by Application (2019-2024) 12.4.1 Global Hepatocyte Growth Factor Sales Forecast by Application (2019-2024) 12.4.2 Global Hepatocyte Growth Factor Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now